Dr. Muhammad R. Raza

An internationally recognized leader in structural heart disease, Dr. Généreux has been a practicing interventional cardiologist for more than 15 years. He is the director of the structural heart program at Morristown Medical Center, has served as the primary or co-investigator on more than 20 clinical trials, and has published more than 350 articles in peer-reviewed journals. He is currently the principal investigator of the EARLY TAVR trial and the PROGRESS trial, two major studies in the field of aortic valve disease. A celebrated clinical researcher since the beginning of his career, he was awarded the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group for the last four years. Dr. Généreux is also involved in multiple early-stage companies in the field of interventional cardiology and heart failure. He received his medical degree from the Université de Montréal, Montréal, Québec, Canada, his cardiology and interventional cardiology degrees from Université de Sherbrooke and Sacré-Coeur Hospital, Montreal, Canada, and performed his advanced interventional cardiology and structural heart fellowship at Columbia University and Cardiovascular Research Foundation, in New York city. Dr. Genereux is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Heart Attack, Coronary Heart Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Genereux is currently accepting new patients.

Howard Herrmann is an Interventional Cardiologist practicing medicine in Philadelphia,, Pennsylvania. Dr. Herrmann is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Mitral Valve Regurgitation, Patent Foramen Ovale, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Herrmann is currently accepting new patients.

An international leader in pediatric cardiology, Christopher J. Petit, MD, has particular expertise in minimally invasive techniques to treat valve disease and complex congenital heart disease. Recognized for his clinical innovations, development of specialty programs, and his research accomplishments, Dr. Petit believes that the field of pediatric cardiology advances through collaborative discovery. He has been an active clinician-scientist, working to determine the best treatments for patients with congenital heart disease. Dr. Petit founded and currently serves as President of the Congenital Cardiac Research Collaborative. Dr. Petit is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Tetralogy of Fallot, Pulmonary Atresia, Pulmonary Atresia with Intact Ventricular Septum, Stent Placement, and Angioplasty. Dr. Petit is board certified in Pediatric Cardiology. Dr. Petit is currently accepting new patients.